JP2019508184A5 - - Google Patents

Download PDF

Info

Publication number
JP2019508184A5
JP2019508184A5 JP2018548904A JP2018548904A JP2019508184A5 JP 2019508184 A5 JP2019508184 A5 JP 2019508184A5 JP 2018548904 A JP2018548904 A JP 2018548904A JP 2018548904 A JP2018548904 A JP 2018548904A JP 2019508184 A5 JP2019508184 A5 JP 2019508184A5
Authority
JP
Japan
Prior art keywords
solution
self
assembling peptide
hydrogel
assembling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018548904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019508184A (ja
JP7049557B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/000312 external-priority patent/WO2017158420A1/en
Publication of JP2019508184A publication Critical patent/JP2019508184A/ja
Publication of JP2019508184A5 publication Critical patent/JP2019508184A5/ja
Application granted granted Critical
Publication of JP7049557B2 publication Critical patent/JP7049557B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018548904A 2016-03-18 2017-03-17 生物組織の癒着の予防 Active JP7049557B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662310121P 2016-03-18 2016-03-18
US201662310131P 2016-03-18 2016-03-18
US62/310,121 2016-03-18
US62/310,131 2016-03-18
PCT/IB2017/000312 WO2017158420A1 (en) 2016-03-18 2017-03-17 Preventing biological tissue adhesion

Publications (3)

Publication Number Publication Date
JP2019508184A JP2019508184A (ja) 2019-03-28
JP2019508184A5 true JP2019508184A5 (https=) 2020-04-23
JP7049557B2 JP7049557B2 (ja) 2022-04-07

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018548904A Active JP7049557B2 (ja) 2016-03-18 2017-03-17 生物組織の癒着の予防

Country Status (11)

Country Link
US (4) US20190091376A1 (https=)
EP (1) EP3429653B1 (https=)
JP (1) JP7049557B2 (https=)
KR (1) KR20190022455A (https=)
CN (1) CN109152868A (https=)
AU (2) AU2017232540A1 (https=)
BR (1) BR112018068941A2 (https=)
CA (1) CA3017684A1 (https=)
CL (1) CL2018002646A1 (https=)
MX (1) MX2018011121A (https=)
WO (1) WO2017158420A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018068941A2 (pt) 2016-03-18 2019-04-16 3-D Matrix, Ltd. prevenção de adesão de tecidos biológicos
EP3818071A2 (en) 2018-07-03 2021-05-12 3-D Matrix, Ltd. Ionic self-assembling peptides
WO2021202577A1 (en) 2020-03-31 2021-10-07 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
KR20250155730A (ko) * 2024-04-24 2025-10-31 경희대학교 산학협력단 하지정맥 수술시 정맥 내벽의 기계 화학적 절제장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3031466B1 (en) 2004-07-06 2018-11-28 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
EP1879606B1 (en) * 2005-04-25 2013-06-12 Massachusetts Institute of Technology Self-assembling peptides for promoting hemostasis
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
KR101670099B1 (ko) * 2008-10-06 2016-10-27 가부시끼가이샤 쓰리디 매트릭스 조직 폐색제
US20140329914A1 (en) * 2011-09-02 2014-11-06 3-D Matrix Ltd. Amphiphilic Peptides for Thoracic Air Leakage Occlusion
HK1215200A1 (zh) * 2012-11-14 2016-08-19 3-D Matrix Ltd. 血管栓塞系统
US20160030628A1 (en) * 2013-03-14 2016-02-04 3-D Matrix, Ltd. Treatment for bile leakage
CN109152861A (zh) 2016-03-18 2019-01-04 立美基股份有限公司 胰瘘堵塞
BR112018068941A2 (pt) 2016-03-18 2019-04-16 3-D Matrix, Ltd. prevenção de adesão de tecidos biológicos
MX2018011201A (es) 2016-03-18 2018-11-22 3 D Matrix Ltd Oclusion de fuga de liquido cefalorraquideo.

Similar Documents

Publication Publication Date Title
JP2019508184A5 (https=)
JP2024100934A (ja) 液体送達組成物
WO2017028025A1 (zh) 贻贝粘蛋白产品及其抑制粘膜炎症的应用
JP6438406B2 (ja) 疎水性生理活性物質を送達するための組成物および方法
JP5954736B2 (ja) 難治性炎症性腸疾患の予防又は治療方法
JP2014221830A5 (https=)
JP6837598B2 (ja) コラーゲンペプチドに基づく医薬組成物及びデバイス、並びにその製造の方法及び使用
JP2011528678A5 (https=)
JP2023109937A (ja) 3-置換1,2,4-オキサジアゾールの結晶形態
Naveed et al. A novel ventricular restraint device (ASD) repetitively deliver Salvia miltiorrhiza to epicardium have good curative effects in heart failure management
MX2014003256A (es) Uso de hidroxamatos de indolilo e indolinilo para tratar insuficiencia cardiaca o lesion neuronal.
WO2023028251A1 (en) Endoscopic, percutaneous and other methods for dissolution of pancreatic necrosis
CN101822643B (zh) 川芎嗪纳米粒及其制备方法和制药中的应用
CN105497019A (zh) 胺类化合物治疗疼痛的医药用途
TW202035415A (zh) 用於治療骨關節炎的化合物
WO2017181978A1 (zh) 贻贝粘蛋白产品及其抑制血管炎症的应用
US20220184110A1 (en) Esophageal stricture suppressing agent
CN113150067B (zh) Gsdme抑制剂及其在肿瘤化疗诱导的消化道损伤防治中的用途
PL235226B1 (pl) Ksantohumol do zastosowania w leczeniu lub zapobieganiu i profilaktyce chorób hemoroidalnych oraz kompozycja zawierająca ksantohumol
AU2008315685A1 (en) Prevention of recurrence of urethral stricture after a conventional treatment
RU2328298C1 (ru) Способ лечения неспецифического язвенного колита
Keller et al. Phenylephrine-induced epistaxis in a six-year-old Quarter horse with nephrosplenic entrapment
WO2008003013A2 (en) Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic
RU2711658C1 (ru) Способ лечения наружного генитального эндометриоза
RU2348403C1 (ru) Способ лечения временного послеоперационного пареза возвратного гортанного нерва при обширных операциях на щитовидной железе